Related Experiment Videos
Toxicology of oncologic drugs
1Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign College of Veterinary Medicine.
Abstract:
The drugs used in clinical oncology are inherently toxic because they are designed to kill host cells. For the most part, the toxic effects occur in tissues with high growth fractions--that is, bone marrow, gastrointestinal epithelium, and hair follicles. Nevertheless, certain drugs do cause harm to other organs. At therapeutic doses of anticancer drugs, the toxicoses are usually mild to moderate and can be managed without undue discomfort to the animal. Occasionally, however, life-threatening cytopenias occur. By contrast, with drug overdose, life-threatening toxicoses can be a very real concern.
Insights
Anticancer drugs are toxic, often affecting rapidly dividing cells like bone marrow. While usually manageable, overdose can lead to severe, life-threatening toxicities in patients.
Area of Science:
- Oncology
- Toxicology
Background:
- Anticancer drugs are cytotoxic by design, targeting rapidly proliferating host cells.
- Commonly affected tissues include bone marrow, gastrointestinal epithelium, and hair follicles due to high growth fractions.
Purpose of the Study:
- To review the toxic effects of anticancer drugs.
- To differentiate between toxicities at therapeutic doses versus overdose.
Main Methods:
- Literature review of anticancer drug toxicities.
Main Results:
- Therapeutic doses of anticancer drugs typically cause mild to moderate toxicities.
- Life-threatening cytopenias can occur occasionally at therapeutic doses.
- Drug overdose significantly increases the risk of severe, life-threatening toxicities.
Conclusions:
- Understanding the dose-dependent toxicity of anticancer agents is crucial for patient management.
- Careful monitoring and dose management are essential to mitigate severe adverse events in oncology patients.